Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.

Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, De Ruysscher D, Peulen H, Belderbos J, Dziadziuszko R, Fink C, Guckenberger M, Hurkmans C, Nestle U.

Br J Radiol. 2015 May 19:20150036. [Epub ahead of print]

PMID:
25873481
2.

SBRT in operable early stage lung cancer patients.

Roesch J, Andratschke N, Guckenberger M.

Transl Lung Cancer Res. 2014 Aug;3(4):212-24. doi: 10.3978/j.issn.2218-6751.2014.08.06. Review.

3.

Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy.

Peulen H, Belderbos J, Guckenberger M, Hope A, Grills I, van Herk M, Sonke JJ.

Radiother Oncol. 2015 Mar;114(3):361-6. doi: 10.1016/j.radonc.2015.02.011. Epub 2015 Mar 11.

PMID:
25770872
4.

Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence?

Guckenberger M.

Expert Rev Anticancer Ther. 2015 May;15(5):525-30. doi: 10.1586/14737140.2015.1023190. Epub 2015 Mar 11.

PMID:
25761997
5.

Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries.

Dahele M, Hatton M, Slotman B, Guckenberger M.

Acta Oncol. 2015 Mar 3:1-5. [Epub ahead of print] No abstract available.

PMID:
25734229
6.

Hypofractionated radiotherapy for prostate cancer.

Hegemann NS, Guckenberger M, Belka C, Ganswindt U, Manapov F, Li M.

Radiat Oncol. 2014 Dec 6;9:275. doi: 10.1186/s13014-014-0275-6.

7.

Intensity-modulated radiotherapy for lung cancer: current status and future developments.

Chan C, Lang S, Rowbottom C, Guckenberger M, Faivre-Finn C; IASLC Advanced Radiation Technology Committee.

J Thorac Oncol. 2014 Nov;9(11):1598-608. doi: 10.1097/JTO.0000000000000346.

PMID:
25436795
8.

Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis.

Guckenberger M, Mantel F, Gerszten PC, Flickinger JC, Sahgal A, Létourneau D, Grills IS, Jawad M, Fahim DK, Shin JH, Winey B, Sheehan J, Kersh R.

Radiat Oncol. 2014 Oct 16;9:226. doi: 10.1186/s13014-014-0226-2.

9.

Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.

Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M.

Strahlenther Onkol. 2015 Feb;191(2):125-32. doi: 10.1007/s00066-014-0739-5. Epub 2014 Aug 27.

PMID:
25159135
10.

Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.

Sterzing F, Brunner TB, Ernst I, Baus WW, Greve B, Herfarth K, Guckenberger M.

Strahlenther Onkol. 2014 Oct;190(10):872-81. doi: 10.1007/s00066-014-0714-1. Epub 2014 Aug 5.

PMID:
25091267
11.

Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases.

Mantel F, Glatz S, Toussaint A, Flentje M, Guckenberger M.

Strahlenther Onkol. 2014 Nov;190(12):1141-8. doi: 10.1007/s00066-014-0706-1. Epub 2014 Jun 27.

PMID:
24969225
12.

Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M, Grosu AL, Guckenberger M.

Strahlenther Onkol. 2014 Jun;190(6):521-32. doi: 10.1007/s00066-014-0648-7. Epub 2014 Apr 9. Review.

PMID:
24715242
13.

Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.

Müller K, Schlamann A, Guckenberger M, Warmuth-Metz M, Glück A, Pietschmann S, Wawer A, Kortmann RD, Kramm C, von Bueren AO.

Strahlenther Onkol. 2014 Apr;190(4):377-81. doi: 10.1007/s00066-013-0513-0. Epub 2014 Feb 19.

PMID:
24638239
14.

Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.

Kestin L, Grills I, Guckenberger M, Belderbos J, Hope AJ, Werner-Wasik M, Sonke JJ, Bissonnette JP, Xiao Y, Yan D; Elekta Lung Research Group.

Radiother Oncol. 2014 Mar;110(3):499-504. doi: 10.1016/j.radonc.2014.02.002. Epub 2014 Mar 11.

PMID:
24630539
15.

Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy.

Serpa M, Baier K, Cremers F, Guckenberger M, Meyer J.

Med Phys. 2014 Mar;41(3):031702. doi: 10.1118/1.4863597.

PMID:
24593706
16.

Stereotactic body radiotherapy for stage I NSCLC: the challenge of evidence-based medicine.

Guckenberger M.

J Thorac Oncol. 2014 Feb;9(2):e17-8. doi: 10.1097/JTO.0000000000000080. No abstract available.

PMID:
24419429
17.

Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.

Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):732-8. doi: 10.1016/j.ijrobp.2013.11.216. Epub 2014 Jan 7.

PMID:
24411630
18.

Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT.

Guckenberger M, Lawrenz I, Flentje M.

Strahlenther Onkol. 2014 Jan;190(1):48-53. doi: 10.1007/s00066-013-0443-x. Epub 2013 Nov 8.

PMID:
24196279
19.

Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.

Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M.

Radiother Oncol. 2013 Oct;109(1):13-20. doi: 10.1016/j.radonc.2013.09.005. Epub 2013 Oct 30.

PMID:
24183066
20.

[Stereotactic body radiotherapy for malignant nodules in the lung].

Nestle U, Guckenberger M.

Zentralbl Chir. 2013 Oct;138 Suppl 1:S25-31. doi: 10.1055/s-0033-1350866. Epub 2013 Oct 22. Review. German.

PMID:
24150852
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk